106 related articles for article (PubMed ID: 2548669)
1. Inhibition of cyclic AMP formation in N1E-115 neuroblastoma cells is mediated by a non-cardiac M2 muscarinic receptor subtype.
Surichamorn W; Amrhein CL; Forray C; el-Fakahany EE
Brain Res; 1989 Jul; 493(2):320-5. PubMed ID: 2548669
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
McKinney M; Anderson DJ; Vella-Rountree L; Connolly T; Miller JH
J Pharmacol Exp Ther; 1991 Jun; 257(3):1121-9. PubMed ID: 1646322
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes.
Yang CM; Chen FF; Sung TC; Hsu HF; Wu D
Am J Physiol; 1993 Sep; 265(3 Pt 1):C666-73. PubMed ID: 8214023
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological coupling and functional role for the muscarinic receptor subtypes in isolated cells from the circular smooth muscle of the rabbit cecum.
Cuq P; Magous R; Bali JP
J Pharmacol Exp Ther; 1994 Oct; 271(1):149-55. PubMed ID: 7965708
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization and distribution of muscarinic receptors in human placental syncytiotrophoblast brush-border and basal plasma membranes.
Pavía J; Muñoz M; Jiménez E; Martos F; Gonzalez-Correa JA; De la Cruz JP; Garcia V; Sanchez de la Cuesta F
Eur J Pharmacol; 1997 Feb; 320(2-3):209-14. PubMed ID: 9059856
[TBL] [Abstract][Full Text] [Related]
6. Study of the muscarinic receptor subtypes in N1E 115 mouse neuroblastoma cells.
Fraeyman NH; Buyse MA; Lefebvre RA
Pharmacol Res; 1991 Jan; 23(1):33-40. PubMed ID: 1646447
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
8. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor subtypes in guinea pig airways.
Haddad EB; Landry Y; Gies JP
Am J Physiol; 1991 Oct; 261(4 Pt 1):L327-33. PubMed ID: 1928368
[TBL] [Abstract][Full Text] [Related]
11. Subtype of muscarinic receptor coupled to the attenuation of hormone-stimulated cAMP accumulation in NG108-15 neuroblastoma x glioma hybrid cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):601-12. PubMed ID: 1282846
[TBL] [Abstract][Full Text] [Related]
12. Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
Dörje F; Wess J; Lambrecht G; Tacke R; Mutschler E; Brann MR
J Pharmacol Exp Ther; 1991 Feb; 256(2):727-33. PubMed ID: 1994002
[TBL] [Abstract][Full Text] [Related]
13. Identification of muscarinic receptor subtypes in mouse parotid gland.
Watson EL; Abel PW; DiJulio D; Zeng W; Makoid M; Jacobson KL; Potter LT; Dowd FJ
Am J Physiol; 1996 Sep; 271(3 Pt 1):C905-13. PubMed ID: 8843721
[TBL] [Abstract][Full Text] [Related]
14. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.
Waelbroeck M; Camus J; Winand J; Christophe J
Life Sci; 1987 Nov; 41(19):2235-40. PubMed ID: 3118122
[TBL] [Abstract][Full Text] [Related]
15. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
Waelbroeck M; Camus J; Tastenoy M; Christophe J
Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses.
Lee NH; Fryer AD; Forray C; el-Fakahany EE
J Pharmacol Exp Ther; 1989 Dec; 251(3):992-9. PubMed ID: 2557423
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
[TBL] [Abstract][Full Text] [Related]
18. Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects.
Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
Eur J Pharmacol; 1991 Feb; 206(2):95-103. PubMed ID: 2065719
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
20. Characterization of muscarinic acetylcholine receptors in cultured adult skin fibroblasts: effects of the Swedish Alzheimer's disease APP 670/671 mutation on binding levels.
Vestling M; Cowburn RF; Venizelos N; Lannfelt L; Winblad B; Adem A
J Neural Transm Park Dis Dement Sect; 1995; 10(1):1-10. PubMed ID: 8619905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
